StocksMedium•5 November 2026•
1 min read
Adicet Bio Q3 Losses Wider Than Analyst Estimates
Key Facts
1Adicet Bio reported a GAAP EPS loss of $1.76, missing analyst estimates by $0.17.
Adicet Bio reported a GAAP EPS loss of $1.76 for the third quarter of 2026. Seeking Alpha reported that the result missed analyst consensus estimates by $0.17, which had anticipated a loss of $1.59 per share.
ACET closed at $3.1 on November 4, 2026, with the stock trading between a low of $2.99 and a high of $3.31 during that session. According to the company, cash, cash equivalents, and short-term investments totaled $100.9 million as of September 30, 2026.